Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	REKTOROVÁ Irena REKTOR Ivan BAREŠ Martin DOSTÁL V. EHLER Edvard FANFRDLOVÁ Zuzana FIEDLER Jiří KLAJBLOVÁ Hana KULIŠŤÁK P. RESSNER Pavel SVÁTOVÁ J. URBÁNEK Karel VELÍSKOVÁ Jana
Year of publication	2003
Type	Article in Periodical
Magazine / Source	European Journal of Neurology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Neurology, neurosurgery, neurosciences
Keywords	depression;dopamine receptor agonists;Parkinson's disease
Description	An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole as add-on to L-dopa therapyon depression in 41 non-demented patients suffering from both mild or moderate depression and advanced Parkinson's disease.
Related projects:	Plasticity of Regulatory Mechanisms of the Central Nervous Systems